• About us
    • History
    • Advantages
    • IPHAR company group
    • Board of directors
    • Scientific council
  • Investment projects
    • Preclinical stage
    • Clinical stage
    • Information for investors
  • Services
    • Drug development
    • Pharmaceutical technology
    • Pharmaceutical development
    • Preclinical trials
    • Pharmaceutical and
      pharmacokinetic analysis
    • Clinical trials
  • Video
  • Skolkovo Collective Use Center
  • Contacts
  • Job offerings
  • RURU
  • About us
    • History
    • Advantages
    • IPHAR company group
    • Board of directors
    • Scientific council
  • Investment projects
    • Preclinical stage
    • Clinical stage
    • Information for investors
  • Services
    • Drug development
    • Pharmaceutical technology
    • Pharmaceutical development
    • Preclinical trials
    • Pharmaceutical and
      pharmacokinetic analysis
    • Clinical trials
  • Video
  • Skolkovo Collective Use Center
  • Contacts
  • Job offerings
  • RURU

IPHAR (Innovative Pharmacology Research, LLC ) Skolkovo FASIE

IPHAR (Innovative Pharmacology Research, LLC )

  • About us
    • History
    • Advantages
    • IPHAR company group
    • Board of directors
    • Scientific council
  • Investment projects
    • Preclinical stage
    • Clinical stage
    • Information for investors
  • Services
    • Drug development
    • Pharmaceutical technology
    • Pharmaceutical development
    • Preclinical trials
    • Pharmaceutical and
      pharmacokinetic analysis
    • Clinical trials
  • Video
  • Skolkovo Collective Use Center
  • Contacts
  • Job offerings
  • RURU

Месяц: July 2017

Антиагрегант компании «Ифар» готов к клиническим испытаниям

24.07.2017No category

Компания «Ифар» завершила доклинические исследования препарата, регулирующего свертываемость крови.

Categories

  • No category
  • Exhibitions
July 2017
M T W T F S S
« Jul   Sep »
 12
3456789
10111213141516
17181920212223
24252627282930
31  

© 2025 IPHAR (Innovative Pharmacology Research, LLC ) All Rights Reserved.